Can Nanotechnology Help in the Fight Against COVID-19?
Overview
Affiliations
Introduction: The current COVID-19 pandemic caused by the SARS-CoV-2 virus demands the development of strategies not only to detect or inactivate the virus, but to treat it (therapeutically and prophylactically). COVID-19 is not only a critical threat for the population with risk factors, but also generates a dramatic economic impact in terms of morbidity and the overall interruption of economic activities.
Areas Covered: Advanced materials are the basis of several technologies that could diminish the impact of COVID-19: biosensors might allow early virus detection, nanosized vaccines are powerful agents that could prevent viral infections, and nanosystems with antiviral activity could bind the virus for inactivation or destruction upon application of an external stimulus. Herein all these methods are discussed under the light of cutting-edge technologies and the previously reported prototypes targeting enveloped viruses similar to SARS-CoV-2. This analysis was derived from an extensive scientific literature search (including pubmed) performed on April 2020.
Expert Opinion: Perspectives on how biosensors, vaccines, and antiviral nanosystems can be implemented to fight COVID-19 are envisioned; identifying the approaches that can be implemented in the short term and those that deserve long term research to cope with respiratory viruses-related pandemics in the future.
Advances in the delivery of anticancer drugs by nanoparticles and chitosan-based nanoparticles.
Jarmila P, Veronika M, Peter M Int J Pharm X. 2024; 8:100281.
PMID: 39297017 PMC: 11408389. DOI: 10.1016/j.ijpx.2024.100281.
Nanotechnology-based theranostic and prophylactic approaches against SARS-CoV-2.
Dhar A, Gupta S, Saini P, Sinha K, Khandelwal A, Tyagi R Immunol Res. 2023; 72(1):14-33.
PMID: 37682455 DOI: 10.1007/s12026-023-09416-x.
Coinfections and Superinfections Associated with COVID-19 in Colombia: A Narrative Review.
Duenas D, Daza J, Liscano Y Medicina (Kaunas). 2023; 59(7).
PMID: 37512147 PMC: 10385172. DOI: 10.3390/medicina59071336.
Adeniyi O, Adebayo O, Akinloye O, Adaramoye O Sci Rep. 2023; 13(1):8513.
PMID: 37231036 PMC: 10212995. DOI: 10.1038/s41598-023-35453-5.
Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2.
Mufamadi M, Ngoepe M, Nobela O, Maluleke N, Phorah B, Methula B Biomed Res Int. 2023; 2023:4588659.
PMID: 37181817 PMC: 10175023. DOI: 10.1155/2023/4588659.